[Effects of schizophyllan on the fate of Mycobacterium tuberculosis within macrophages and lungs of mice (author's transl)].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002478:Cells, Cultured; D004977:Ethambutol / Q000494:pharmacology / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000494:pharmacology* / Q000627:therapeutic use; D008168:Lung / Q000382:microbiology*; D008264:Macrophages / Q000166:cytology / Q000382:microbiology*; D008297:Male; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D010587:Phagocytosis; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D006025:Glycosaminoglycans; D004977:Ethambutol; D012293:Rifampin